Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
scROSHI: robust supervised hierarchical identification of single cells.
Prummer M, Bertolini A, Bosshard L, Barkmann F, Yates J, Boeva V; Tumor Profiler Consortium; Stekhoven D, Singer F. Prummer M, et al. NAR Genom Bioinform. 2023 Jun 16;5(2):lqad058. doi: 10.1093/nargab/lqad058. eCollection 2023 Jun. NAR Genom Bioinform. 2023. PMID: 37332656 Free PMC article.
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
Mamot C, Wicki A, Hasler-Strub U, Riniker S, Li Q, Holer L, Bärtschi D, Zaman K, von Moos R, Dedes KJ, Boos LA, Novak U, Bodmer A, Ritschard R, Obermann EC, Tzankov A, Ackermann C, Membrez-Antonioli V, Zürrer-Härdi U, Caspar CB, Deuster S, Senn M, Winterhalder R, Rochlitz C. Mamot C, et al. Among authors: wicki a. Sci Rep. 2023 Mar 6;13(1):3705. doi: 10.1038/s41598-023-30950-z. Sci Rep. 2023. PMID: 36879012 Free PMC article. Clinical Trial.
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.
Mehra T, Dongre K, Boesing M, Frei P, Suenderhauf C, Zippelius A, Leuppi JD, Wicki A, Leuppi-Taegtmeyer AB. Mehra T, et al. Among authors: wicki a. Cancer Med. 2023 Jun;12(11):12253-12262. doi: 10.1002/cam4.5919. Epub 2023 Apr 21. Cancer Med. 2023. PMID: 37084178 Free PMC article.
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study.
Jolidon V, Eicher M, Peytremann-Bridevaux I, Aebi S, Anchisi S, Bettini A, Chalandon Y, Dietrich PY, Duchosal MA, Dürr D, Peters S, von Moos R, Wicki A, Arditi C. Jolidon V, et al. Among authors: wicki a. Cancer. 2024 Dec 15;130(24):4334-4346. doi: 10.1002/cncr.35506. Epub 2024 Aug 9. Cancer. 2024. PMID: 39119752 Free PMC article.
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16.
Bastian S, Joerger M, Holer L, Bärtschi D, Guckenberger M, Jochum W, Koeberle D, Siebenhüner AR, Wicki A, Berger MD, Winterhalder RC, Largiadèr CR, Löffler M, Mosna-Firlejczyk K, Maranta AF, Pestalozzi BC, Csajka C, von Moos R; Swiss Group for Clinical Cancer Research (SAKK). Bastian S, et al. Among authors: wicki a. Clin Colorectal Cancer. 2024 Oct 23:S1533-0028(24)00088-4. doi: 10.1016/j.clcc.2024.10.002. Online ahead of print. Clin Colorectal Cancer. 2024. PMID: 39537446
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.
Christ SM, Heesen P, Muehlematter UJ, Pohl K, William Thiel G, Willmann J, Ahmadsei M, Kroese TE, Mayinger M, Balermpas P, Wicki A, Andratschke N, Huellner M, Guckenberger M. Christ SM, et al. Among authors: wicki a. Clin Transl Radiat Oncol. 2022 Nov 15;38:123-129. doi: 10.1016/j.ctro.2022.11.008. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36420098 Free PMC article.
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center.
von der Grün J, Ahmadsei M, Breyer I, Britschgi C, Eberli D, Hermanns T, Mangana J, Petrowsky H, Ramelyte E, Roth P, Schär G, Opitz I, Weller M, Wicki A, Witzel I, Balermpas P, Guckenberger M. von der Grün J, et al. Among authors: wicki a. Neoplasia. 2023 Oct 27;46:100946. doi: 10.1016/j.neo.2023.100946. Online ahead of print. Neoplasia. 2023. PMID: 39491410 Free PMC article.
Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study.
Rieger MJ, Schenkel X, Dedic I, Brunn T, Gnannt R, Hofmann M, de Rougemont O, Stolz SM, Rösler W, Studt JD, Balabanov S, Wicki A, Lorch A, Manz MG, Schwotzer R. Rieger MJ, et al. Among authors: wicki a. Int J Cancer. 2023 Oct 1;153(7):1397-1405. doi: 10.1002/ijc.34612. Epub 2023 May 30. Int J Cancer. 2023. PMID: 37254629
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.
Eichhoff OM, Stoffel CI, Käsler J, Briker L, Turko P, Karsai G, Zila N, Paulitschke V, Cheng PF, Leitner A, Bileck A, Zamboni N, Irmisch A, Balazs Z, Tastanova A, Pascoal S, Johansen P, Wegmann R, Mena J, Othman A, Viswanathan VS, Wenzina J, Aloia A, Saltari A, Dzung A; TuPro Consortium; Krauthammer M, Schreiber SL, Hornemann T, Distel M, Snijder B, Dummer R, Levesque MP. Eichhoff OM, et al. Cancer Res. 2023 Apr 4;83(7):1128-1146. doi: 10.1158/0008-5472.CAN-22-1826. Cancer Res. 2023. PMID: 36946761
99 results